ETON ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥11/5/2026
EPSå®çžŸïŒUSDïŒ1.23
売äžé«å®çžŸïŒUSDïŒ57.92M
Eton Pharmaceuticals Incã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® Eton Pharmaceuticals Inc ã®æ±ºç®å ±åæžã次å Eton Pharmaceuticals Inc ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãEton Pharmaceuticals Inc ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠Eton Pharmaceuticals Inc ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
ETON 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
ETON FY2025 決ç®
EPS (å幎åææ¯)-0.17-15.82%
売äžé« (å幎åææ¯)79.95M104.94%
Eton Pharmaceuticals IncïŒETONïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 11/5/2026 | 09/2026 | 1.23/0.31 | 57.92M/38.86M | 293.56% | 49.05% |
| 8/13/2026 | 06/2026 | 0.42/0.10 | 37.59M/27.12M | 298.91% | 38.61% |
| 5/14/2026 | 03/2026 | 0.06/0.09 | 24.27M/22.31M | -36.72% | 8.76% |
| 3/19/2026 | 12/2025 | 0.06/0.09 | 21.28M/20.58M | -38.88% | 3.41% |
| 11/6/2025 | 09/2025 | -0.07/0.09 | 22.46M/20.47M | -179.61% | 9.70% |
| 8/7/2025 | 06/2025 | -0.10/-0.04 | 18.93M/16.71M | -162.12% | 13.26% |
| 5/13/2025 | 03/2025 | -0.06/0.05 | 17.28M/15.13M | -209.64% | 14.22% |
| 3/18/2025 | 12/2024 | -0.02/-0.00 | 11.65M/10.53M | -587.09% | 10.60% |
Eton Pharmaceuticals Inc ææ°ã®æ±ºç®é»è©±äŒè°èšé²î
ã€ãŒãã³ã»ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºïŒETONïŒ2026幎第3ååæ決ç®èª¬æäŒïŒå£²äžé«ã158%æ¥å¢ãã¬ã€ãã³ã¹ãåŒãäžã
ã€ãŒãã³ã»ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºã®2026幎第3ååæ決ç®èª¬æäŒã§ã¯ã売äžé«ã158%å¢ã®5,790äžãã«ã«éããããšãã調æŽåŸEBITDAããŒãžã³ã49%ãšãªã£ãããšããªãã³ã«2026幎éæã¬ã€ãã³ã¹ã®åŒãäžãã«ã€ããŠèª¬æãããŸããã